Literature DB >> 18759163

Antibodies against mutated citrullinated vimentin fail to predict anti-TNFalpha treatment response in rheumatoid arthritis.

C Dejaco, C Duftner, W Klotz, M Schirmer, M Herold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 18759163     DOI： 10.1080/03009740802220067

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  3 in total

1.  Third generation anti-cyclic citrullinated peptide antibodies do not predict anti-TNF-alpha treatment response in rheumatoid arthritis.

Authors:  Christian Dejaco; Christina Duftner; Werner Klotz; Michael Schirmer; Manfred Herold
Journal:  Rheumatol Int       Date:  2009-06-09       Impact factor: 2.631

Review 2.  Autoantibodies as Diagnostic Markers and Mediator of Joint Inflammation in Arthritis.

Authors:  Qinghua Fang; Jiaxin Ou; Kutty Selva Nandakumar
Journal:  Mediators Inflamm       Date:  2019-10-27       Impact factor: 4.711

Review 3.  Biomarkers in Rheumatoid Arthritis, what is new?

Authors:  B I Gavrilă; C Ciofu; V Stoica
Journal:  J Med Life       Date:  2016 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.